Knowledge Ecology International

http://wikileaks.org/cable/2005/11/05GENEVA2798.html

Cable subject: Wto Trips Council October 25-26 2005
Cable written Wed, 16 Nov 2005 09:17 UTC

TRANSITION PERIOD FOR LEAST-DEVELOPED COUNTRIES-REQUEST FOR EXTENSION

39. Zambian Ambassador introduced LDC proposal to extend transitional period for TRIPS Compliance by An additional 15 years. He stressed points concerning that resource and economic difficulties LDCs face and the costs of implementing TRIPS obligations. Tanzania, Uganda, Cambodia, Senegal, Lesotho all supported Zambia’s statement.

Continue Reading →

Among the cables recently published by Wilileaks is one written on November 24, 2009, detailing negotiations between USTR and Anand Sharma, the Cabinet Minister for Commerce and Industry of the Government of India. The complete cable is available here: http://wikileaks.org/cable/2009/11/09NEWDELHI2375.html

Continue Reading →

August 28, 2011
From KEI staff review of Wikileaks cables (/wikileaks)

Among the many new cables released by Wikileaks is this gem, a detailed account of the U.S. government pressure on the Guatemala legislature to shape legislation on pharmaceutical test data IPR.

http://wikileaks.org/cable/2005/03/05GUATEMALA659.html

C O N F I D E N T I A L SECTION 01 OF 05 GUATEMALA 000659

SIPDIS
E.O. 12958: DECL: 03/11/2010

TAGS: ETRD KIPR PGOV PREL GT

 Continue Reading →
		

Posted August 27, 2011

These are some tools for searching the US Department of State cables released by Wikileaks.

A Wikileaks page on the cables is available here: http://wlcentral.org/cablegate

KEI recommends this site for searching the cables by key words:

http://cablegatesearch.net/search.php

You might also want to try:

• http://cabledrum.net

Continue Reading →

As part of the American University hosted Global Congress on Intellectual Property and the public Interest, I participated in a panel on the positive agenda for intellectual property. These are notes from my talk.

Presentation by Manon Anne Ress, Knowledge Ecology International
August 26, 2011, at American University in Washington, DC

Continue Reading →

AIDS Drug Assistance Programs (ADAP) serve low-income, underinsured or uninsured HIV-positive patients in the United States and its territories. General eligibility requirements may include residency, clinical eligibility based on specific CD4 counts, and income. Specific eligibility criteria for each ADAP is determined by each individual state. Continue Reading →

The number of patients sitting on AIDS Drug Assistance Programs (ADAP) wait lists, denied the life-saving treatment they need, have risen dramatically over the past two years. ADAPs are critical in providing HIV/AIDS treatment to low-income, uninsured, or underinsured patients within the United States and its territories. As noted in an earlier KEI blog, in January 2010, 361 individuals were on ADAP waitlists; that number grew to 7,873 across eleven states as of May 5, 2011 (a 2100% increase over less than sixteen months).

Continue Reading →

In the first seven months of 2011 (January 14 to July 20) , the US FDA has already approved 18 new molecular entity drugs. These are some notes on the approvals:

• All of the NME products are considered pharmaceutical drugs, and received approval under FDA procedures for New Drug Applications (NDA).
• Despite the trends indiciating shifts to biologic products from pharmaceutical drugs, none of the 2011 products introduced to date were biologics.
• One third (6 of 18) received Priority review status. 12 of 18 received Standard review status.

Continue Reading →